M&A Fireworks: Shire Buys Jerini For €328 Million

Jerini secures a hefty payout, despite FDA deeming HAE candidate Firazyr “not approvable.”

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet